Multiple targets in iron metabolism and erythropoiesis pathways

"Multiple targets in iron metabolism and erythropoiesis pathways" refers to the interconnected molecular systems governing body iron absorption, distribution, utilization, and storage, as well as the production and maturation of erythrocytes (red blood cells). Key molecular targets within these pathways include the hormone hepcidin (regulator of systemic iron homeostasis), ferroportin (the principal cellular iron exporter), iron transport proteins (such as transferrin and its receptors), iron storage proteins (ferritin), enzymes involved in heme synthesis (ALAS1, ALAS2, ferrochelatase), and key signaling molecules such as erythropoietin and its receptor. These targets are involved in diseases ranging from iron deficiency anemia and thalassemia to hereditary hemochromatosis and some myeloproliferative disorders. Modulation of these molecules with drugs, biologics, or gene therapies aims to restore appropriate iron balance and effective erythropoiesis[1][2][4][5][6][7][10]. This designation is too broad and does not correspond to a single defined molecule or drug target; instead, it represents a functional category encompassing numerous protein targets and signaling molecules central to iron biology and red cell physiology[1][2][4][5]. For structured data or database entry, referral should instead be to **specific gene or protein names (e.g., Hepcidin, Ferroportin, Transferrin receptor 1)** rather than the multiplex descriptive category provided.

Other names

iron metabolism actorserythropoiesis regulatorsiron homeostasis proteinserythroid pathway targetsiron transporters

Modulation of hepcidin levels; Inhibition or activation of iron transporters (e.g., ferroportin); Suppression or stimulation of erythropoietin signaling; Support or inhibition of iron absorption and cellular uptake; Induction or prevention of iron sequestration; Other pathway-specific mechanisms